Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best ...
People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...
A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...
Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish ...
A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...
Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...
Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...
With state-of-the-art facilities and internationally renowned researchers, we are pioneering technologies to improve the diagnosis and monitoring of cancer, and to guide new forms of precision ...
Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...
Professor Sebastian Guettler is Deputy Head of the Division of Structural Biology. He studies the precise molecular mechanisms of signalling processes central to cancer stem cell function, with a ...
The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...
Professor Axel Behrens' group uses a combination of sophisticated genetics and human cancer organoids to understand the biology of cancer and to develop novel therapeutic options, with an emphasis on ...